Eclipse Bio
3 known investors
Eclipsebio provides RNA biology expertise and analytical technologies for drug developers and researchers, offering AI-powered sequence design, nucleotide-level characterization, and sequencing-based assays across small oligonucleotides, small molecules targeting RNA, AI training data, and basic research applications.
AI & Machine LearningBiotechDeep Tech
Investors · 3
In the news
- Eclipsebio Raises $14M in Series A Financing - FinSMEsfinsmes.com · 2022
- Biotech startup Eclipsebio emerges to shed light on RNA drug research - MedCity Newsmedcitynews.com · 2022
- Eclipsebio Announces a $14 Million Series A Financing to Advance Its RNA Genomics Technology Platformprnewswire.com · 2022